Affiliation:
1. Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
Abstract
Ulcerative colitis (UC) is an inflammatory bowel disease that mainly affects young people. Colorectal cancer (CRC) is one of the UC complications. This review considers the epidemiology, risk factors, diagnosis and screening, and drug prevention of CRC in UC. Various treatment options for dysplasia and CRC associated with UC are described. Taking into account the lack of literature to standardize colorectal cancer treatment approaches (especially rectal cancer) for UC, further studies are warranted to evaluate both oncological and functional treatment outcomes.
Publisher
Russian Association of Coloproctology
Subject
Gastroenterology,Oncology,Surgery
Reference63 articles.
1. Sung H, Ferlay J, Siegel RL et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–49. doi: 10.3322/CAAC.21660
2. Ivashkin V.T., Shelygin Yu.A., Khalif I.L. et al. Clinical guide of Russian association of gastroenterology and Russian Association of coloproctology on diagnostics and treatment of ulcerative colitis. Koloproctologia. 2017:6–30. (in Russ.). doi: 10.33878/2073-7556-2017-0-1
3. Kaplan GG, Ng SC. Understanding and Preventing the Global Increase of Inflammatory Bowel Disease. Gastroenterology. 2017;152:313–321.e2. doi: 10.1053/J.GASTRO.2016.10.020
4. Jess T, Simonsen J, Jorgensen KT, Pedersen BV, Nielsen NM, Frisch M. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology. 2012;143:375–381. e1. doi: 10.1053/J.GASTRO.2012.04.016
5. Triantafillidis JK, Nasioulas G, Kosmidis PA. Colorectal Cancer and Inflammatory Bowel Disease: Epidemiology, Risk Factors, Mechanisms of Carcinogenesis and Prevention Strategies. Anticancer Research. Anticancer Res. 2009;29:2727–38.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献